ISSCR News
Janet Rossant Named as New Stem Cell Reports Editor-in-Chief Starting in 2025
The International Society for Stem Cell Research (ISSCR) announces the appointment of Janet Rossant, President of the Gairdner Foundation and Senior Scientist Emeritus at the Hospital for Sick Children, Canada as the next Stem Cell Reports Editor-in-Chief beginning 1 January 2025. Dr. Rossant will take over the position held by Martin Pera, The Jackson Laboratory, USA, for nearly six years.
Plenary Speakers and Key Deadlines Announced for ISSCR 2025 Annual Meeting in Hong Kong
The International Society for Stem Cell Research (ISSCR) convenes world-renown scientists dedicated to stem cell research and regenerative medicine each year at its annual meeting to share the year’s most compelling basic discoveries and clinical breakthroughs in the stem cell field. Abstract submission and registration for ISSCR 2025, taking place 11-14 June 2025, will open on 2 October 2024. Abstracts submitted by 21 January 2025 will be considered for oral presentations and merit and travels awards.
New in Stem Cell Reports: New Stem Cell Research May Have Implications for Liver Transplantation
Research just published in the journal Stem Cell Reports, provides proof of principle that functional liver cells can be grown in a different species and could represent a solution to transplant shortage.
The ISSCR Announces Hong Kong, SAR As Location For Its 2025 Annual Meeting
The world’s leading stem cell scientists will convene in Hong Kong, SAR, 11-14 June 2025 for the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, illuminating the future of stem cell science and highlighting the most compelling research and clinical advances of the year.
New in Stem Cell Reports: Blood Stem Cells Unlock Clues for Helping Sepsis Patients Fight Recurring Infections
Severe sepsis from bacterial or viral infections can be life-threatening and even people recovering from severe sepsis may experience long-lasting effects on the immune system, making them more susceptible to recurrent infections. The causes for this sepsis-induced immune suppression are not well understood and lack an effective treatment. To better understand the cause, Katherine MacNamara and colleagues from Albany Medical College, USA, analyzed the blood stem cells of mice with prior sepsis and their results were recently published in the journal Stem Cell Reports.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .